ARTICLE | Company News
Merck, Kyorin deal
January 12, 2015 8:00 AM UTC
Merck’s MSD K.K. subsidiary granted Kyorin co-marketing and co-promotion rights in Japan to desloratadine. The second-generation histamine H1 receptor antagonist is in Phase III testing to treat alle...